STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00005646 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer

NCT00034164 ·Status: COMPLETED ·Phase: PHASE2

Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer

NCT00004126 ·Status: COMPLETED ·Phase: PHASE2

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.

NCT00047840 ·Status: COMPLETED ·Phase: PHASE2

Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer

NCT00016315 ·Status: COMPLETED ·Phase: PHASE1

Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer

NCT00003281 ·Status: COMPLETED ·Phase: PHASE2

2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC)

NCT00835471 ·Status: COMPLETED ·Phase: PHASE2

A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

NCT04623775 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00085501 ·Status: COMPLETED ·Phase: PHASE2

A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)

NCT00257608 ·Status: COMPLETED ·Phase: PHASE3

Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer

NCT00004265 ·Status: UNKNOWN ·Phase: PHASE2

S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer

NCT00004137 ·Status: COMPLETED ·Phase: PHASE2

S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer

NCT00003158 ·Status: COMPLETED ·Phase: PHASE2

A Study of Bevacizumab With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic Melanoma

NCT00434252 ·Status: COMPLETED ·Phase: PHASE2

Paclitaxel in Treating Patients With Lung Cancer

NCT00002972 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00006215 ·Status: UNKNOWN ·Phase: PHASE2

Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer

NCT00475657 ·Status: TERMINATED ·Phase: PHASE2

Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00118131 ·Status: TERMINATED ·Phase: PHASE2

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

NCT00553462 ·Status: COMPLETED ·Phase: PHASE2

A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung Cancer

NCT00789373 ·Status: COMPLETED ·Phase: PHASE3

Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer

NCT00004924 ·Status: COMPLETED ·Phase: PHASE2

A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer

NCT00047736 ·Status: COMPLETED ·Phase: PHASE3

Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer

NCT01048645 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma

NCT00407459 ·Status: COMPLETED ·Phase: PHASE2

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

NCT00418743 ·Status: UNKNOWN